Funding for multi-site acquisitions and pharmacy groups, where the assessment is consolidated rather than branch by branch.
What changes at group scale
A single branch acquisition is assessed on that branch; see pharmacy acquisition finance for how that works. Once you are acquiring several, or buying an existing group, lenders assess the consolidated position: combined EBITDA, contract exposure across the estate, management depth and the integration plan.
That opens up funders who will not look at a single pharmacy, and structures that are not available on a one-branch deal. Asset-based facilities for acquisitions, management buy-outs and buy-and-build strategies can run well into the millions where the underlying business supports it.
Our guide to pharmacy valuation explains how EBITDA multiples feed into what lenders will advance.
Where group deals get complicated
- Contract concentration. An estate heavily weighted to one type of income or one geography is assessed differently from a diversified one.
- Management depth. A group running on one person’s involvement is a risk lenders price for. Evidence of a management layer matters more with each site.
- Mixed tenure. A portfolio combining freeholds and leaseholds on varying terms needs the property element structuring separately from the trading facility.
- Integration. Lenders will want to know how systems, staff and stock are being brought together, and what it costs.
Structuring for the next deal
If a buy-and-build is the plan, structure the first two acquisitions with that in mind. Facilities arranged deal by deal, with different lenders on different terms, become an obstacle by the fourth site, and unpicking them costs more than setting them up correctly would have.
A structure that anticipates further acquisitions, with headroom and consistent security, is worth more than a marginally cheaper standalone facility on deal one. Plan the working capital across the estate at the same time, because stock and reimbursement timing scale with every branch you add.
Management buy-outs
Where an existing management team is acquiring the group, asset-based structures are well suited: they lend against the value in the business, which can reduce the equity the team needs to find. Some personal contribution is still usually expected. This is specialist territory and the lender panel is different from single-branch lending.
If any member of the team plans to raise their contribution against their own home, that borrowing is a regulated residential mortgage. We do not arrange it; they would need an FCA-authorised mortgage adviser for that part.
Common questions
How many branches before this applies?
There is no fixed threshold, but around three sites is where consolidated assessment and asset-based structures usually become the better route. It is worth planning for before you reach it.
Can I acquire a group with a mix of freehold and leasehold?
Yes, though the property and trading elements are usually funded separately. A mixed estate is normal and manageable; it just needs structuring rather than treating as one facility. See pharmacy commercial mortgages for the property side.
Is a group easier or harder to fund than a single branch?
Different rather than harder. There is more to assess, but also more security, more diversification and access to funders who do not operate at single-branch scale.
All figures are indicative and subject to lender assessment, your circumstances, valuation and prevailing market conditions. Commercial mortgages and unregulated bridging loans are not regulated by the Financial Conduct Authority. Property offered as security may be at risk if you do not keep up repayments.